Abstract
From 1984 to 1996, 31 consecutive children without sibling donors, aged 5–19 years (median 8) with acute lymphoblastic leukaemia (ALL) in second complete remission (CR), received unpurged autologous bone marrow transplantation (ABMT) after melphalan and single fraction total body irradiation (TBI). ABMT was performed using fresh unmanipulated marrow harvested after standard reinduction and consolidation therapy 2–11 months (median 5) after relapse. With a median survival of 2.9 years the probability of survival for all patients in continuing second CR was 45.1% (95% CI, 24%-62%) after 5 years. Regimen-related and non-leukaemia mortality was 7% (95% CI, 2%-26%). The longest time to second relapse from ABMT was 3.1 years. Pituitary and gonadal dysfunction requiring hormonal replacement therapy occurred in the majority of long-term survivors. Twelve patients developed cataracts. ABMT with melphalan/single fraction TBI has proved an effective anti-leukaemia treatment with low regimen-related mortality but significant long-term morbidity. The current approach of allogeneic BMT from an unrelated donor when no sibling donor is available, following conditioning with cyclophosphamide/ fractionated TBI has resulted in a reduced relapse rate and improved short-term overall survival in the treatment of relapsed childhood ALL. However, long-term results are awaited. Bone Marrow Transplantation (2000) 25, 599–603.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rivera GK, Pinkel D, Simon JV et al. Treatment of acute lymphoblastic leukaemia. 30 years’ experience at St Jude Children's Research Hospital New Engl J Med 1993 329: 1289–1295
Chessells JM . Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects Blood Rev 1992 6: 193–203
Wheeler K, Richards S, Bailey C et al. Comparison of bone marrow transplantation and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience Br J Haematol 1998 101: 94–103
Gaynon PS, Qu RP, Chappell RJ et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse: the Children's Cancer Group experience Cancer 1998 82: 1387–1395
Dopfer R, Henze G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission after intensive primary and relapse therapy according to BFM and coALL protocols: results of the German Co-operative Society Blood 1991 78: 2780–2784
Uderzo C, Valsechi MG, Bacigalupo A et al. Treatment of childhood acute lymphoblastic leukaemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-years’ experience of the Italian Pediatric Hematology Oncology Association J Clin Oncol 1995 13: 352–358
Barrett AJ, Horowitz MM, Pollock B et al. Bone marrow transplantation from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in second remission New Engl J Med 1994 331: 1253–1258
Borgmann A, Schmid H, Hartmann R et al. Autologous bone marrow transplant compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis Lancet 1995 346: 873–876
Parsons SK, Castellino SM, Lehmann LE et al. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic transplantation in selected children Bone Marrow Transplant 1996 17: 763–768
Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukaemia New Engl J Med 1987 20: 461–467
Billet AL, Kornmehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukaemia Blood 1993 81: 1651–1657
Helenglass G, Powles RL, McElwain TJ et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloid leukaemia in first remission Bone Marrow Transplant 1988 3: 21–29
Carey P, Proctor SJ, Taylor P et al. Autologous bone marrow transplantation for high grade lymphoid malignancy using melphalan irradiation conditioning without marrow purging or cryopreservation Blood 1991 77: 1593–1598
Schroeder H, Pinkerton CR, Powles RL et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse Bone Marrow Transplant 1991 7: 11–15
Eden OB, Lilleyman JS, Richards S et al. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII: report to the Medical Research Medical Council on behalf of the Working Party on Leukaemia in Childhood Br J Haematol 1991 76: 187–196
Chessells JM, Bailey C, Richards S . Intensification of treatment and survival in all children with lymphoblastic leukaemia Lancet 1995 345: 143–148
Chessells JM, Bailey C, Wheeler K et al. Bone marrow transplantation for high risk childhood acute lymphoblastic leukaemia in first remission: experience in MRC UKALL-X Lancet 1992 340: 565–568
Sallan SE, Niemeyer CM, Billet AL et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia J Clin Oncol 1989 7: 1594–1601
Weisdorf DJ, Billet AL, Hannan P et al. Autologous versus unrelated donor allogeneic marrow transplantation for ALL Blood 1997 90: 2962–2968
Messina C, Cesaro S, Rondelli R . Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy Bone Marrow Transplant 1998 21: 1015–1021
Messina C, Sotti G, Loiacona G et al. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukaemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato Oncologia Pediatrica Bone Marrow Transplant 1998 21: 9–14
Sutton L, Kuentz M, Cordonnier C et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukaemia in first complete remission. Factors predictive of transplant related mortality and influence of total body irradiation modalities Bone Marrow Transplant 1993 12: 583–589
Morgan TL, Falk PM, Kogut N et al. A comparison of single dose and fractionated total body irradiation on the development of pneumonitis following bone marrow transplantation Int J Radiat Oncol Biol Phys 1996 36: 61–66
Belkacemi Y, Pene F, Touboul E et al. Total body irradiation before bone marrow transplantation for acute leukaemia in first or second complete remission: results and prognostic factors in 326 consecutive patients Strahlenther-Onkol 1998 174: 92–104
Thomas BC, Stanhope R, Plowman PN, Leiper AD . Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood Acta Endocrinol Copenh 1993 128: 508–512
Ogilvy- Stuart AL, Clark DJ, Wallace WHB et al. Endocrine deficit after fractionated total body irradiation Arch Dis Child 1992 67: 1107–1110
Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia Lancet 1997 350: 767–771
Oakhill A, Pamphilon DH, Porter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 1996 94: 574–578
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaidya, S., Atra, A., Bahl, S. et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission – long-term follow-up. Bone Marrow Transplant 25, 599–603 (2000). https://doi.org/10.1038/sj.bmt.1702214
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702214
Keywords
This article is cited by
-
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL
Bone Marrow Transplantation (2011)
-
TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions
Bone Marrow Transplantation (2011)
-
Long-term renal function following bone marrow transplantation
Bone Marrow Transplantation (2007)
-
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983–1998
Bone Marrow Transplantation (2005)
-
Autologous stem cell transplantation in hematological malignancies
Springer Seminars in Immunopathology (2004)